[COPD固定三重疗法在现实生活中的利用:Trilife研究. 贝克洛米他/福莫特醇/糖皮龙三重固定剂量疗法在超细颗粒中]
N Roche1, A Bernady2, D Piperno3
1Pneumologie, hôpital Cochin, Assistance publique-Hôpitaux de Paris (AP-HP), Paris, France.
Revue des maladies respiratoires
|November 2, 2024
概括
在Trilife的研究中发现,法国75.1%的用于COPD的贝克洛美沙/形式/糖皮龙处方符合产品指南. 这些真实数据也表明了患者的改善结果和对这种三重治疗的坚持.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 现实世界的证据.
背景情况:
- 在Trilife研究中,评估了贝克洛美沙/格洛美/糖皮龙的现实使用情况,这是一种三重定剂量组合吸入疗法.
- 这种药物适用于中度至重度慢性阻塞性肺病 (COPD) 的持续治疗.
研究的目的:
- 在现实环境中,评估贝克罗梅他/形式/糖皮龙处方与产品特性摘要 (SPC) 的遵守程度.
- 在六个月的随访期间评估患者的结果,包括坚持,临床状态和生活质量.
主要方法:
- 一项前性,非干预性,多中心研究,涉及法国的肺病学家.
- 346名中度至重度COPD患者接受了6个月的随访,以评估处方遵守和临床结果.
主要成果:
- 在75.1%的患者 (95% CI: [70.6; 79.7]) 中,观察到处方符合SPC.
- 吸烟是唯一与SPC合规性有显著关联的变量 (P=0.019).
- 该研究还表明,患者坚持治疗的程度提高,恶化减少,呼吸障碍改善,生活质量改善,治疗满意度增加.
结论:
- 在法国,大约四分之三的贝克罗米他/格洛莫特醇/糖皮龙处方符合SPC指南.
- 这些发现支持这种三重疗法在治疗慢性慢性病的适当使用,并强调其对患者福祉的积极影响.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:23Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K